[1]
C, E., L, S.W., AZ, F.A. , A, A., A, A.H., MN, N.A., S, S. and C, J. 2019. PREVALANE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies. 34, (Jul. 2019), 21.